A series of heteroleptic bis(phthalocyaninato) europium(III) complexes, namely, Eu(Pc)[Pc(15C5)] (2), Eu(Pc)[Pc(opp-15C5)2] (3), Eu(Pc)[Pc(adj-15C5)2] (4), Eu(Pc)[Pc(15C5)3] (5), and Eu(Pc)[Pc(15C5)4] (6) [Pc = unsubstituted phthalocyaninate; Pc(15C5) = 2,3-(15-crown-5)phthalocyaninate; Pc(opp-15C5)2 = 2,3,16,17-bis(15-crown-5)phthalocyaninate; Pc(adj-15C5)2 = 2,3,9,10-bis(15-crown-5)phthalocyaninate; Pc(15C5)3 = 2,3,9,10,16,17-tris(15-crown-5)phthalocyaninate, Pc(15C5)4 = 2,3,9,10,16,17,24,25-tetrakis(15-crown-5)phthalocyaninate], with one, two, three, and four 15-crown-5 voids attached at different positions of one of the two phthalocyaninato ligands in the double-decker molecules, have been devised and prepared by Eu(Pc)(acac)-induced (Hacac = acetylacetone) mixed cyclization of the two corresponding phthalonitriles in the presence of organic base 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in n-pentanol. For the purpose of comparative studies, homoleptic counterparts Eu(Pc)2 (1) and Eu[Pc(15C5)4]2 (7) have also been prepared. These sandwich double-decker complexes have been characterized by a wide range of spectroscopic methods in addition to elemental analysis. Their electrochemistry has also been studied by cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The molecular structure of Eu(Pc)[Pc(15C5)4] (6) has been determined by X-ray diffraction analysis. Their supramolecular structure-formation properties, in particular for compounds 5 and 6 in the presence of potassium ions, have also been comparatively studied for the purpose of future functional investigation.
No takes yet. Share an insight, caveat, or question.
Sheng et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: